$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?
07:30am, Sunday, 08'th Oct 2023
Exact Sciences and Guardant Health have both enjoyed triple-digit revenue growth over the past five years. Exact Sciences' shares are up more than 31% so far this year, while Guardant is up a little m
Guardant Health (GH) Surges 8.8%: Is This an Indication of Further Gains?
09:46am, Friday, 29'th Sep 2023
Guardant Health (GH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Why Guardant Health Stock Jumped 15% This Week
04:22pm, Thursday, 28'th Sep 2023
Analysts at both Bernstein and Piper Sandler had good things to say about Guardant Health this week. Shares of the precision oncology company had plunged more than 35% in September despite a lack of c
Why Guardant Health Stock Popped Again Today
11:25am, Thursday, 28'th Sep 2023
Guardant Health stock has lost half its value over the past year. That's the bad news.
Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
04:05pm, Thursday, 31'st Aug 2023
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming Morgan Stanley 21st Annual Gl
Wall Street Analysts Believe Guardant Health (GH) Could Rally 42.09%: Here's is How to Trade
07:32pm, Tuesday, 22'nd Aug 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 42.1% in Guardant Health (GH). While the effectiveness of this highly sought-after metric is questionable, the
2 Cathie Wood Stocks to Buy and Hold for 10 Years
09:53am, Thursday, 10'th Aug 2023
Guardant Health's fight against cancer is also proving to be profitable for the company. Pinterest is looking to benefit from e-commerce in addition to its advertising business.
Guardant Health, Inc. (GH) Q2 2023 Earnings Call Transcript
11:57pm, Thursday, 03'rd Aug 2023
Guardant Health, Inc. (NASDAQ:GH ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Carrie Mendivil - IR Helmy Eltoukhy - Co-Founder, Co-CEO & Chairman AmirAli Talasaz -
Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates
07:32pm, Thursday, 03'rd Aug 2023
Guardant Health (GH) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $1.25. This compares to loss of $2.25 per share a year ago.
Guardant Health to Report Second Quarter 2023 Financial Results on August 3, 2023
04:05pm, Wednesday, 12'th Jul 2023
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will report financial results for the second quarter of 2023 a
Guardant Health: A Growth Company Expanding Its Product Line Quickly
06:14pm, Monday, 10'th Jul 2023
Guardant Health's share price has been volatile over the past year, but with strong clinical volume growth, the company presents an interesting investment opportunity. The company has diversified its
3 Stocks, 1 Potentially Explosive Growth Theme | June 5, 2023
09:27am, Monday, 05'th Jun 2023
#Morningstar #StockMarket #Investing Plus our take on Nvidia stock and our market outlook for June. Read more from David Sekera here: https://www.morningstar.com/stocks/2-undervalued-medtech-stocks-op
Guardant Health stock falls after secondary offering announced
04:46pm, Monday, 22'nd May 2023
Guardant Health Inc. GH, +2.46% shares fell in the extended session Monday after the cancer testing company announced a secondary offering of its stock. Guardant shares rose as much as 8% after hours,
Why Shares of Guardant Health Jumped This Week
05:50pm, Friday, 19'th May 2023
Guardant said its Guardant360 liquid biopsy is receiving coverage from all four major U.S. health insurers. The company grew revenue by 34% in the first quarter, year over year, but had a net loss.
Guardant Health, Inc. (GH) Q1 2023 Earnings Call Transcript
11:38pm, Tuesday, 09'th May 2023
Guardant Health, Inc. (NASDAQ:GH ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Alex Kleban - Vice President-Investor Relations Helmy Eltoukhy - Chairman & Co-Chief Exe
Sign In
Buy GH